| |
|
|
| GET ready to rock! Queen tribute act The
Kings of Queen are to play a charity concert to raise funds for The Katie
Trust next year. The gig will take place at the Middlesbrough Theatre on Tuesday, May 8, 2007 and the support act will be a tribute to Elton John. Kings of Queen front man Dave Kinghorn is able to recreate the magic of singer Freddie Mercury with spectacular effect during the band's stunning stage show, while guitarist Paul Wilson has studied Brian May's style and sound - and it shows! The concert is being promoted by Middlesbrough Erimus Rotary Club and proceeds will be split between The Katie Trust and Rotary charities. Tickets (priced £14) will be available from early October. To reserve yours or for further information please contact The Katie Trust on 01642 470856 or send an e-mail to katietrust@btinternet.com |
|
|
A TABLE top sale in aid of The Katie Trust will take place
at the Baptist Church Hall, Bruce Grove, Shotgate, on Saturday, October
21 (10am start).
Household goods, records, toys, clothes and more
will be on sale. There will also be tea and coffee on sale plus a mouth-watering
selection of cakes.
FANCY A COFFEE?
OUR annual coffee morning at Laburnum Road Library, Redcar, takes place
on Tuesday, October 24.
The usual selection of delicious home-baked cakes will be
on sale along with teas, coffees and cold drinks. There will be a tombola
and raffle too - there's something for everyone and it all starts at 10.30am.
Another coffee morning also takes place at St Catherine's
Church Hall, Southend Road, Wickford, Essex, on Saturday October 28 (from
10am). There will be teas, coffees and cold drinks available plus a sale
of bric-a-brac and plants.
MAID IN HEAVEN!
|
THE Katie Trust's annual participation in the BUPA
Great North Run proved another great success. Chairman Martin Neal was again among the 20 or so runners in the Katie Trust team, this year sporting a rather fetching French maid's outfit - feather duster and all - and he is pictured with his medal at the end of the world's biggest half-marathon which takes place from Newcastle to South Shields. Ian Rudd from Redcar also dressed up - he was a pirate and, along with Martin and Paul Chandler from Brecon, collected money for The Katie Trust in a bucket along the route. It is hoped that this year's Katie Trust team will collect another four-figure sum in sponsorship money - all of which, as usual, will help to further our charitable aims. We are very grateful for the help of Jill and Tony Budd, their company PTP Consultants Lt of Basildon, Essex, and Linda, Paul and Jenny Chandler for their help in making this year's event such a success for us. We took two mini-buses full of runners up to this year's event - and The Katie Trust even got a mention over the tannoy at the start! Next year we want our team to be bigger and more successful than ever. We're looking for serious runners, not so serious runners and people who want to dress up in a silly costume and have a laugh. The 2007 BUPA Great North Run takes place on Sunday, September, 30 - let us know if you would like to join our team. |
THE third Katie Trust medulloblastoma research post
was launched at the Northern Institute for Cancer Research in Newcastle
upon Tyne on October 1st, 2004.
Yuan Lu, a talented young Chinese student, has already spent a year at the NICR as a Masters degree student and impressed greatly in that time and has now been appointed to the new Katie Trust PhD medulloblastoma research post.
Yuan follows Charles McManamy and Jennifer Anderton, the
incumbents of our first two three-year posts.
Jennifer Anderton began work on the second Katie Trust project - called Identification of Tumour Suppresser Genes in Medulloblastoma - in October 2002.
The team in Newcastle have discovered a previously
unknown gene which plays a major role in the growth of medulloblastoma
tumours and Jennifer has been following up those leads.
The work of our Katie Trust students
will hopefully help to discover why the gene behaves as
it does - and ultimately lead to less severe forms of the
disease being recognised, thus sparing the patient aggressive chemotherapy
and radiotherapy treatment and the development of new drugs.